INBX Overview
Upcoming Projects (INBX)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (INBX)
-
Discussing AATD and COPD, focusing on Inhibrx's INBRX-101 and Verona's ensifentrine
Tickers: INBX, VRNA
Executed On: Sep 27, 2023 at 11:00 AM EDT -
Exploring the potential of INBX-101, a recombinant AAT Fc-fusion protein, in treating patients with AATD
Ticker: INBX
Executed On: Sep 11, 2023 at 11:00 AM EDT -
A discussion of Fazirsiran and its potential in A1AT liver disease ahead of the phase 2 placebo controlled SEQUOIA trial
Tickers: ARWR, VRTX, INBX
Executed On: Nov 18, 2022 at 12:00 PM EST
Expired Projects (INBX)
-
Exploring the Potential of INBRX-109 in Ewing Sarcoma Treatment: A Deep Dive into Inhibrx's Latest Clinical Trial Results
Ticker: INBX
Execute By: Feb 29, 2024
Upcoming & Overdue Catalysts (INBX)
-
Don’t see a catalyst related to the company you care about? Create your own!
Strategic Initiatives (INBX)
-
Don’t see a strategic initiative related to the company you care about? Create your own!
